Our Clients

The CMSU markets itself to the Pharmaceutical and Medical Device industries and fellow academic institutions as a fully cGMP compliant clinical packaging, labeling and distribution service provider to the clinical trials industry. CMSU is also utilized by several multi-center investigator-initiated consortia including the Parkinson Study Group (PSG), the Huntington Study Group (HSG), the Neuroprotective Exploratory Trials Group (NET-PD) and the NeuroNEXT Network for Excellence in Neuroscience Clinical Trials where funding is received from various sources including Pharma, Foundations and the National Institutes of Health (NIH). These study groups are comprised of more than 400 academic investigators and coordinators from the United States, Canada, Europe and Australia and have included complex packaging schemes and resupply distribution channels spanning more than 5 years for some trials.